Cargando…
Effect of fenofibrate and selective PPARα modulator (SPPARMα), pemafibrate on KATP channel activity and insulin secretion
OBJECTIVE: Insulin secretion is regulated by ATP-sensitive potassium (K(ATP)) channels in pancreatic beta-cells. Peroxisome proliferator-activated receptors (PPAR) α ligands are clinically used to treat dyslipidemia. A PPARα ligand, fenofibrate, and PPARγ ligands troglitazone and 15-deoxy-∆(12,14)-p...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494450/ https://www.ncbi.nlm.nih.gov/pubmed/37697384 http://dx.doi.org/10.1186/s13104-023-06489-7 |
_version_ | 1785104695169122304 |
---|---|
author | Kitamura, Shigeki Murao, Naoya Yokota, Shoko Shimizu, Masaru Ono, Tomoyuki Seino, Yusuke Suzuki, Atsushi Maejima, Yuko Shimomura, Kenju |
author_facet | Kitamura, Shigeki Murao, Naoya Yokota, Shoko Shimizu, Masaru Ono, Tomoyuki Seino, Yusuke Suzuki, Atsushi Maejima, Yuko Shimomura, Kenju |
author_sort | Kitamura, Shigeki |
collection | PubMed |
description | OBJECTIVE: Insulin secretion is regulated by ATP-sensitive potassium (K(ATP)) channels in pancreatic beta-cells. Peroxisome proliferator-activated receptors (PPAR) α ligands are clinically used to treat dyslipidemia. A PPARα ligand, fenofibrate, and PPARγ ligands troglitazone and 15-deoxy-∆(12,14)-prostaglandin J2 are known to close K(ATP) channels and induce insulin secretion. The recently developed PPARα ligand, pemafibrate, became a new entry for treating dyslipidemia. Because pemafibrate is reported to improve glucose intolerance in mice treated with a high fat diet and a novel selective PPARα modulator, it may affect K(ATP) channels or insulin secretion. RESULTS: The effect of fenofibrate (100 µM) and pemafibrate (100 µM) on insulin secretion from MIN6 cells was measured by using batch incubation for 10 and 60 min in low (2 mM) and high (10 mM) glucose conditions. The application of fenofibrate for 10 min significantly increased insulin secretion in low glucose conditions. Pemafibrate failed to increase insulin secretion in all of the conditions experimented in this study. The K(ATP) channel activity was measured by using whole-cell patch clamp technique. Although fenofibrate (100 µM) reduced the K(ATP) channel current, the same concentration of pemafibrate had no effect. Both fenofibrate and pemafibrate had no effect on insulin mRNA expression. |
format | Online Article Text |
id | pubmed-10494450 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-104944502023-09-12 Effect of fenofibrate and selective PPARα modulator (SPPARMα), pemafibrate on KATP channel activity and insulin secretion Kitamura, Shigeki Murao, Naoya Yokota, Shoko Shimizu, Masaru Ono, Tomoyuki Seino, Yusuke Suzuki, Atsushi Maejima, Yuko Shimomura, Kenju BMC Res Notes Research Note OBJECTIVE: Insulin secretion is regulated by ATP-sensitive potassium (K(ATP)) channels in pancreatic beta-cells. Peroxisome proliferator-activated receptors (PPAR) α ligands are clinically used to treat dyslipidemia. A PPARα ligand, fenofibrate, and PPARγ ligands troglitazone and 15-deoxy-∆(12,14)-prostaglandin J2 are known to close K(ATP) channels and induce insulin secretion. The recently developed PPARα ligand, pemafibrate, became a new entry for treating dyslipidemia. Because pemafibrate is reported to improve glucose intolerance in mice treated with a high fat diet and a novel selective PPARα modulator, it may affect K(ATP) channels or insulin secretion. RESULTS: The effect of fenofibrate (100 µM) and pemafibrate (100 µM) on insulin secretion from MIN6 cells was measured by using batch incubation for 10 and 60 min in low (2 mM) and high (10 mM) glucose conditions. The application of fenofibrate for 10 min significantly increased insulin secretion in low glucose conditions. Pemafibrate failed to increase insulin secretion in all of the conditions experimented in this study. The K(ATP) channel activity was measured by using whole-cell patch clamp technique. Although fenofibrate (100 µM) reduced the K(ATP) channel current, the same concentration of pemafibrate had no effect. Both fenofibrate and pemafibrate had no effect on insulin mRNA expression. BioMed Central 2023-09-11 /pmc/articles/PMC10494450/ /pubmed/37697384 http://dx.doi.org/10.1186/s13104-023-06489-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Note Kitamura, Shigeki Murao, Naoya Yokota, Shoko Shimizu, Masaru Ono, Tomoyuki Seino, Yusuke Suzuki, Atsushi Maejima, Yuko Shimomura, Kenju Effect of fenofibrate and selective PPARα modulator (SPPARMα), pemafibrate on KATP channel activity and insulin secretion |
title | Effect of fenofibrate and selective PPARα modulator (SPPARMα), pemafibrate on KATP channel activity and insulin secretion |
title_full | Effect of fenofibrate and selective PPARα modulator (SPPARMα), pemafibrate on KATP channel activity and insulin secretion |
title_fullStr | Effect of fenofibrate and selective PPARα modulator (SPPARMα), pemafibrate on KATP channel activity and insulin secretion |
title_full_unstemmed | Effect of fenofibrate and selective PPARα modulator (SPPARMα), pemafibrate on KATP channel activity and insulin secretion |
title_short | Effect of fenofibrate and selective PPARα modulator (SPPARMα), pemafibrate on KATP channel activity and insulin secretion |
title_sort | effect of fenofibrate and selective pparα modulator (spparmα), pemafibrate on katp channel activity and insulin secretion |
topic | Research Note |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494450/ https://www.ncbi.nlm.nih.gov/pubmed/37697384 http://dx.doi.org/10.1186/s13104-023-06489-7 |
work_keys_str_mv | AT kitamurashigeki effectoffenofibrateandselectivepparamodulatorspparmapemafibrateonkatpchannelactivityandinsulinsecretion AT muraonaoya effectoffenofibrateandselectivepparamodulatorspparmapemafibrateonkatpchannelactivityandinsulinsecretion AT yokotashoko effectoffenofibrateandselectivepparamodulatorspparmapemafibrateonkatpchannelactivityandinsulinsecretion AT shimizumasaru effectoffenofibrateandselectivepparamodulatorspparmapemafibrateonkatpchannelactivityandinsulinsecretion AT onotomoyuki effectoffenofibrateandselectivepparamodulatorspparmapemafibrateonkatpchannelactivityandinsulinsecretion AT seinoyusuke effectoffenofibrateandselectivepparamodulatorspparmapemafibrateonkatpchannelactivityandinsulinsecretion AT suzukiatsushi effectoffenofibrateandselectivepparamodulatorspparmapemafibrateonkatpchannelactivityandinsulinsecretion AT maejimayuko effectoffenofibrateandselectivepparamodulatorspparmapemafibrateonkatpchannelactivityandinsulinsecretion AT shimomurakenju effectoffenofibrateandselectivepparamodulatorspparmapemafibrateonkatpchannelactivityandinsulinsecretion |